Diabetes Care

DIABETES CARE, published by the American Diabetes Association (ADA), is a premier peer-reviewed medical journal dedicated to advancing the prevention, diagnosis, and management of diabetes and its complications. With an ISSN of 0149-5992 and a 2026 Impact Factor of 22.600, it is consistently ranked in the JCR Q1 (top quartile) of both the Endocrinology & Metabolism and General & Internal Medicine categories, reflecting its exceptional influence and citation impact in the field. The journal’s scope encompasses a broad spectrum of clinical and translational research, including original investigations on epidemiology, pathophysiology, therapeutics, health services research, behavioral interventions, and emerging technologies such as continuous glucose monitoring and artificial pancreas systems. DIABETES CARE publishes a diverse array of article types, including original research articles, comprehensive reviews, brief reports, commentaries, and ADA position statements that often set clinical practice standards. Its target audience includes endocrinologists, primary care physicians, diabetes educators, researchers, and public health professionals. Notable features include a rigorous single-blind peer-review process, a strong emphasis on evidence-based practice, and open access options for authors to comply with funder mandates. As the official journal of the ADA, it also serves as a key platform for disseminating the ADA’s annual Standards of Care, making it an indispensable resource for clinicians and researchers worldwide. Its top-tier impact factor and Q1 standing underscore its role as a leading authority in diabetes research and clinical care.